CpG island shore methylation regulates caveolin-1 expression in breast cancer

X. Rao, J. Evans, H. Chae, J. Pilrose, S. Kim, P. Yan, R. L. Huang, H. C. Lai, H. Lin, Yunlong Liu, D. Miller, J. K. Rhee, Y. W. Huang, F. Gu, J. W. Gray, Th M. Huang, Kenneth Nephew

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Caveolin-1 (Cav1) is an integral membrane, scaffolding protein found in plasma membrane invaginations (caveolae). Cav1 regulates multiple cancer-associated processes. In breast cancer, a tumor suppressive role for Cav1 has been suggested; however, Cav1 is frequently overexpressed in aggressive breast cancer subtypes, suggesting an oncogenic function in advanced-stage disease. To further delineate Cav1 function in breast cancer progression, we evaluated its expression levels among a panel of cell lines representing a spectrum of breast cancer phenotypes. In basal-like (the most aggressive BC subtype) breast cancer cells, Cav1 was consistently upregulated, and positively correlated with increased cell proliferation, anchorage-independent growth, and migration and invasion. To identify mechanisms of Cav1 gene regulation, we compared DNA methylation levels within promoter 'CpG islands' (CGIs) with 'CGI shores', recently described regions that flank CGIs with less CG-density. Integration of genome-wide DNA methylation profiles ('methylomes') with Cav1 expression in 30 breast cancer cell lines showed that differential methylation of CGI shores, but not CGIs, significantly regulated Cav1 expression. In breast cancer cell lines having low Cav1 expression (despite promoter CGI hypomethylation), we found that treatment with a DNA methyltransferase inhibitor induced Cav1 expression via CGI shore demethylation. In addition, further methylome assessments revealed that breast cancer aggressiveness associated with Cav1 CGI shore methylation levels, with shore hypermethylation in minimally aggressive, luminal breast cancer cells and shore hypomethylation in highly aggressive, basal-like cells. Cav1 CGI shore methylation was also observed in human breast tumors, and overall survival rates of breast cancer patients lacking estrogen receptor α (ERα) negatively correlated with Cav1 expression. Based on this first study of Cav1 (a potential oncogene) CGI shore methylation, we suggest this phenomenon may represent a new prognostic marker for ERα-negative, basal-like breast cancer.

Original languageEnglish
Pages (from-to)4519-4528
Number of pages10
JournalOncogene
Volume32
Issue number38
DOIs
StatePublished - Sep 19 2013

Fingerprint

Caveolin 1
CpG Islands
Methylation
Breast Neoplasms
DNA Methylation
Cell Line
Estrogen Receptors
Caveolae
Methyltransferases
Oncogenes

Keywords

  • breast cancer
  • Cav1
  • CpG island shore
  • DNA methylation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

CpG island shore methylation regulates caveolin-1 expression in breast cancer. / Rao, X.; Evans, J.; Chae, H.; Pilrose, J.; Kim, S.; Yan, P.; Huang, R. L.; Lai, H. C.; Lin, H.; Liu, Yunlong; Miller, D.; Rhee, J. K.; Huang, Y. W.; Gu, F.; Gray, J. W.; Huang, Th M.; Nephew, Kenneth.

In: Oncogene, Vol. 32, No. 38, 19.09.2013, p. 4519-4528.

Research output: Contribution to journalArticle

Rao, X, Evans, J, Chae, H, Pilrose, J, Kim, S, Yan, P, Huang, RL, Lai, HC, Lin, H, Liu, Y, Miller, D, Rhee, JK, Huang, YW, Gu, F, Gray, JW, Huang, TM & Nephew, K 2013, 'CpG island shore methylation regulates caveolin-1 expression in breast cancer', Oncogene, vol. 32, no. 38, pp. 4519-4528. https://doi.org/10.1038/onc.2012.474
Rao X, Evans J, Chae H, Pilrose J, Kim S, Yan P et al. CpG island shore methylation regulates caveolin-1 expression in breast cancer. Oncogene. 2013 Sep 19;32(38):4519-4528. https://doi.org/10.1038/onc.2012.474
Rao, X. ; Evans, J. ; Chae, H. ; Pilrose, J. ; Kim, S. ; Yan, P. ; Huang, R. L. ; Lai, H. C. ; Lin, H. ; Liu, Yunlong ; Miller, D. ; Rhee, J. K. ; Huang, Y. W. ; Gu, F. ; Gray, J. W. ; Huang, Th M. ; Nephew, Kenneth. / CpG island shore methylation regulates caveolin-1 expression in breast cancer. In: Oncogene. 2013 ; Vol. 32, No. 38. pp. 4519-4528.
@article{4bf56c0d2aca464bb8bb74ccff4af35a,
title = "CpG island shore methylation regulates caveolin-1 expression in breast cancer",
abstract = "Caveolin-1 (Cav1) is an integral membrane, scaffolding protein found in plasma membrane invaginations (caveolae). Cav1 regulates multiple cancer-associated processes. In breast cancer, a tumor suppressive role for Cav1 has been suggested; however, Cav1 is frequently overexpressed in aggressive breast cancer subtypes, suggesting an oncogenic function in advanced-stage disease. To further delineate Cav1 function in breast cancer progression, we evaluated its expression levels among a panel of cell lines representing a spectrum of breast cancer phenotypes. In basal-like (the most aggressive BC subtype) breast cancer cells, Cav1 was consistently upregulated, and positively correlated with increased cell proliferation, anchorage-independent growth, and migration and invasion. To identify mechanisms of Cav1 gene regulation, we compared DNA methylation levels within promoter 'CpG islands' (CGIs) with 'CGI shores', recently described regions that flank CGIs with less CG-density. Integration of genome-wide DNA methylation profiles ('methylomes') with Cav1 expression in 30 breast cancer cell lines showed that differential methylation of CGI shores, but not CGIs, significantly regulated Cav1 expression. In breast cancer cell lines having low Cav1 expression (despite promoter CGI hypomethylation), we found that treatment with a DNA methyltransferase inhibitor induced Cav1 expression via CGI shore demethylation. In addition, further methylome assessments revealed that breast cancer aggressiveness associated with Cav1 CGI shore methylation levels, with shore hypermethylation in minimally aggressive, luminal breast cancer cells and shore hypomethylation in highly aggressive, basal-like cells. Cav1 CGI shore methylation was also observed in human breast tumors, and overall survival rates of breast cancer patients lacking estrogen receptor α (ERα) negatively correlated with Cav1 expression. Based on this first study of Cav1 (a potential oncogene) CGI shore methylation, we suggest this phenomenon may represent a new prognostic marker for ERα-negative, basal-like breast cancer.",
keywords = "breast cancer, Cav1, CpG island shore, DNA methylation",
author = "X. Rao and J. Evans and H. Chae and J. Pilrose and S. Kim and P. Yan and Huang, {R. L.} and Lai, {H. C.} and H. Lin and Yunlong Liu and D. Miller and Rhee, {J. K.} and Huang, {Y. W.} and F. Gu and Gray, {J. W.} and Huang, {Th M.} and Kenneth Nephew",
year = "2013",
month = "9",
day = "19",
doi = "10.1038/onc.2012.474",
language = "English",
volume = "32",
pages = "4519--4528",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "38",

}

TY - JOUR

T1 - CpG island shore methylation regulates caveolin-1 expression in breast cancer

AU - Rao, X.

AU - Evans, J.

AU - Chae, H.

AU - Pilrose, J.

AU - Kim, S.

AU - Yan, P.

AU - Huang, R. L.

AU - Lai, H. C.

AU - Lin, H.

AU - Liu, Yunlong

AU - Miller, D.

AU - Rhee, J. K.

AU - Huang, Y. W.

AU - Gu, F.

AU - Gray, J. W.

AU - Huang, Th M.

AU - Nephew, Kenneth

PY - 2013/9/19

Y1 - 2013/9/19

N2 - Caveolin-1 (Cav1) is an integral membrane, scaffolding protein found in plasma membrane invaginations (caveolae). Cav1 regulates multiple cancer-associated processes. In breast cancer, a tumor suppressive role for Cav1 has been suggested; however, Cav1 is frequently overexpressed in aggressive breast cancer subtypes, suggesting an oncogenic function in advanced-stage disease. To further delineate Cav1 function in breast cancer progression, we evaluated its expression levels among a panel of cell lines representing a spectrum of breast cancer phenotypes. In basal-like (the most aggressive BC subtype) breast cancer cells, Cav1 was consistently upregulated, and positively correlated with increased cell proliferation, anchorage-independent growth, and migration and invasion. To identify mechanisms of Cav1 gene regulation, we compared DNA methylation levels within promoter 'CpG islands' (CGIs) with 'CGI shores', recently described regions that flank CGIs with less CG-density. Integration of genome-wide DNA methylation profiles ('methylomes') with Cav1 expression in 30 breast cancer cell lines showed that differential methylation of CGI shores, but not CGIs, significantly regulated Cav1 expression. In breast cancer cell lines having low Cav1 expression (despite promoter CGI hypomethylation), we found that treatment with a DNA methyltransferase inhibitor induced Cav1 expression via CGI shore demethylation. In addition, further methylome assessments revealed that breast cancer aggressiveness associated with Cav1 CGI shore methylation levels, with shore hypermethylation in minimally aggressive, luminal breast cancer cells and shore hypomethylation in highly aggressive, basal-like cells. Cav1 CGI shore methylation was also observed in human breast tumors, and overall survival rates of breast cancer patients lacking estrogen receptor α (ERα) negatively correlated with Cav1 expression. Based on this first study of Cav1 (a potential oncogene) CGI shore methylation, we suggest this phenomenon may represent a new prognostic marker for ERα-negative, basal-like breast cancer.

AB - Caveolin-1 (Cav1) is an integral membrane, scaffolding protein found in plasma membrane invaginations (caveolae). Cav1 regulates multiple cancer-associated processes. In breast cancer, a tumor suppressive role for Cav1 has been suggested; however, Cav1 is frequently overexpressed in aggressive breast cancer subtypes, suggesting an oncogenic function in advanced-stage disease. To further delineate Cav1 function in breast cancer progression, we evaluated its expression levels among a panel of cell lines representing a spectrum of breast cancer phenotypes. In basal-like (the most aggressive BC subtype) breast cancer cells, Cav1 was consistently upregulated, and positively correlated with increased cell proliferation, anchorage-independent growth, and migration and invasion. To identify mechanisms of Cav1 gene regulation, we compared DNA methylation levels within promoter 'CpG islands' (CGIs) with 'CGI shores', recently described regions that flank CGIs with less CG-density. Integration of genome-wide DNA methylation profiles ('methylomes') with Cav1 expression in 30 breast cancer cell lines showed that differential methylation of CGI shores, but not CGIs, significantly regulated Cav1 expression. In breast cancer cell lines having low Cav1 expression (despite promoter CGI hypomethylation), we found that treatment with a DNA methyltransferase inhibitor induced Cav1 expression via CGI shore demethylation. In addition, further methylome assessments revealed that breast cancer aggressiveness associated with Cav1 CGI shore methylation levels, with shore hypermethylation in minimally aggressive, luminal breast cancer cells and shore hypomethylation in highly aggressive, basal-like cells. Cav1 CGI shore methylation was also observed in human breast tumors, and overall survival rates of breast cancer patients lacking estrogen receptor α (ERα) negatively correlated with Cav1 expression. Based on this first study of Cav1 (a potential oncogene) CGI shore methylation, we suggest this phenomenon may represent a new prognostic marker for ERα-negative, basal-like breast cancer.

KW - breast cancer

KW - Cav1

KW - CpG island shore

KW - DNA methylation

UR - http://www.scopus.com/inward/record.url?scp=84884588875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884588875&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.474

DO - 10.1038/onc.2012.474

M3 - Article

C2 - 23128390

AN - SCOPUS:84884588875

VL - 32

SP - 4519

EP - 4528

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 38

ER -